Candace Crogan-Grundy

Candace Crogan-Grundy has a diverse work experience spanning several industries. Candace currently holds the position of Director, Quality Control at Abzena, a bioconjugate- and biologics-focused CDMO. Candace joined Abzena in 2021 and is responsible for developing and implementing innovative solutions that enable biotech and biopharma companies to realize the full potential of their investments in human health.

Prior to joining Abzena, Candace worked at Sequoia Consulting Group, LLC as a Consulting Manager, Quality and Regulatory. Candace also served as a Principal Validation Scientist at the same company. Before that, they worked at Organovo Holdings, Inc. where they held various positions including Consultant, Associate Director, Tissue Platform Operations, and Senior Manager, Testing Core. Candace managed teams, executed customer projects/studies, and contributed to revenue generation for the business unit.

Candace's earlier experience includes roles at Shire as a Research Specialist II - Research Process Development, Amylin Pharmaceuticals as a Research Associate II - Cell Biology, EpiCept Corporation as a Research Associate III - HTS Biology, Maxim Pharmaceuticals as a Research Associate II - HTS Biology and Research Associate I, and Thomas & Betts as a Regional Quotation Manager/Inside Sales.

Overall, Candace's work experience demonstrates their expertise in quality control, regulatory compliance, and project management within the pharmaceutical and biotechnology industries.

Candace Crogan-Grundy has a Bachelor of Science (B.S.) degree in Biochemistry from California State University San Marcos.